Occupational stresses in anesthesiology: Dependence syndromes in anesthesiologists;Berufliche Belastungen in der Anästhesiologie Abhä ngigkeitssyndrome bei Anästhesisten

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 45, Issue 10, 2010, Pages 648-655

  Maier, Christoph ^a   Iwunna, Judith ^a   Soukup, Jens ^a   Scherbaum, Norbert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIOLOGY; ANESTHESIST; DEPENDENT PERSONALITY DISORDER; HUMAN; JOB STRESS; REVIEW;

ANALGESICS, OPIOID; ANESTHESIOLOGY; ANESTHETICS; EUROPE; GERMANY; HUMANS; PERSONALITY; PHYSICIAN IMPAIRMENT; RECURRENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 78049281399     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-0030-1267531     Document Type: Review

References (80)

1. Benn G. Aus: Deutsche Gedichte. Hrsg K. Krolow, Band II, Frankfurt a.M Insel Verlag 1982
2. Kimpel V. Schriftsteller Ärzte. Hürtgenwald Guido Pressler Verlag 1999
3. Schäfer D. Opium des Volkes und Droge der Dichter Schlafmohn in Medizin und Belletristik des 19. Jahrhunderts. Dtsch med Wochenschr 2009 134 2607-2611
4. Seefelder M. Opium. Eine Kulturgeschichte. Frankfurt am Main Athenäum Verlag 1987
5. Johnson RP, Connelly JC. Addicted physicians. A closer look. JAMA 1981 245 253-257
6. ICD 10. www.dimdi.de/static/de/klassi/diagnosen/icd10/htmlgm2010/block- f10-f19.htm 2010 06 30
7. Laux G. Abhängigkeit und Sucht. In: Möller HJ Laux G Deister A (Hrsg) Psychiatrie und Psychotherapie. Stuttgart Thieme 2009 Aufl
8. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004 112 65-75
9. Gilson AM. The concept of addiction in law and regulatory policy related to pain management: a critical review. Clin J Pain 2010 26 70-77
10. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007 129 235-255
11. Jage J, Willweber-Strumpf A, Maier C. Risikofaktoren für Missbrauch und Abhängigkeit bei der Opioidtherapie chronischer nicht tumorbedingter Schmerzen. Schmerz 2005 19 434-440
12. Maier C. Auch Sucht ist eine Krankheit. Schmerz 2008 22 639-643
13. Scherbaum N, Jage J, Kindler D, Maier C. Diagnostik, Therapie und Prävention der Opioidabhängigkeit. In: Diener HC Maier C (Hrsg.) Die Schmerztherapie. München Jena Urban & Fischer 2009 3 Aufl
14. Wasan AD, Correll DJ, Kissin I, O'Shea S, Jamison RN. Iatrogenic addiction in patients treated for acute or subacute pain: a systematic review. J Opioid Manag 2006 2 16-22
15. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985 142 1259-1264
16. Hyman SE. Addiction: a disease of learning and memory. Am J Psychiatry 2005 162 1414-1422
17. Koob GF, Nestler EJ. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997 9 482-497
18. Leshner AI. Addiction is a brain disease, and it matters. Science 1997 278 45-47
19. Wise RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008 14 169-183
20. Marshall EJ. Doctors' health and fitness to practise: treating addicted doctors. Occup Med 2008 58 334-340
21. Yücel M, Lubman DI, Solowij N, Brewer WJ. Understanding drug addiction: a neuropsychological perspective. Aust N Z J Psychiatry 2007 41 957-968
22. Wallace JE, Lemaire JB, Ghali WA. Physician wellness: a missing quality indicator. Lancet 2009 374 1714-1721
23. Reissner V et al. Burnout, coping and job satisfaction in service staff treating opioid addicts from Athens to Zurich. Stress and Health 2009 26 149-159
24. Berke JD, Hyman SE. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000 25 515-532
25. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002 159 1642-1652
26. Kalivas PW. Addiction as a pathology in prefrontal cortical regulation of corticostriatal habit circuitry. Neurotox Res 2008 14 185-189
27. Koob GF, Ahmed SH, Boutrel B et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 2004 27 739-749
28. Robinson TE, Berridge KC. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 2008 363 3137-3146
29. Cocteau J. Tagebuch eines Entwöhnten. Aus: Der Querschnitt Das Magazin der aktuellen Ewigkeitswerte, September 1930. www.g26.ch/texte-cocteau- 01.html. 2010 7 10
30. Li KY, Xiao C, Xiong M, Delphin E, Ye JH. Nanomolar propofol stimulates glutamate transmission to dopamine neurons: a possible mechanism of abuse potential? J Pharmacol Exp Ther 2008 325 165-174
31. Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol 2007 21 459-466
32. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006 29 565-598
33. Terenius L, Johansson B. The opioid systems - panacea and nemesis. Biochem Biophys Res Commun 2010 396 140-142
34. Duncan EJ et al. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 2001 25 72-83
35. Sinner B, Graf BM. Ketamine. Handb Exp Pharmacol 2008 182 313-333
36. Foll BL, Gallo A, Le Strat Y, Lu L, Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 2009 20 1-17
37. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur Psychiatry 2000 15 79-89
38. Walton R, Johnstone E, Munafo M, Neville M, Griffiths S. Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. Trends Mol Med 2001 7 70-76
39. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995 38 95-137
40. Robledo P. Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction. Curr Drug Targets 2010 11 429-439
41. Boening JA. Neurobiology of an addiction memory. J Neural Transm 2001 108 755-765
42. Schultz W. Dopamine signals for reward value and risk: basic and recent data. Behav Brain Funct 2010 6 24-24
43. Bonnet U, Harkener J, Scherbaum N. A case report of propofol dependence in a physician. J Psychoactive Drugs 2008 40 215-217
44. Walker DJ, Beckman NJ, Zacny JP. Reinforcing and subjective effects of the volatile anesthetic, sevoflurane. Drug Alcohol Depend 2004 76 191-201
45. Domenighetti G. Psychoactive drug use among medical doctors is higher than in the general population. Soc Sci Med 1991 33 269-274
46. Domino KB, Hornbein TF, Polissar NL et al. Risk factors for relapse in health care professionals with substance use disorders. Jama 2005 293 1453-1460
47. Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull 1988 14 116-122
48. Gravenstein JS, Kory WP, Marks RG. Drug abuse by anesthesia personnel. Anesth Analg 1983 62 467-472
49. Wischmeyer PE, Johnson BR, Wilson JE et al. A survey of propofol abuse in academic anesthesia programs. Anesth Analg table of contents 2007 105
50. Passie T, Metzner C, Borsutzky M, Schneider U. Propofolabhängigkeit. Suchtmedizin 2001 2 228-232
51. Cicero TJ, Surratt H, Inciardi JA, Munoz A. Relationship between therapeutic use and abuse of opioid analgesics in rural,suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf 2007 16 827-840
52. Skipper GE, DuPont RL. Anesthesiologists returning to work after substance abuse treatment. Anesthesiology author reply 2009 110 1426-1428
53. Gold MS, Melker RJ, Dennis DM et al. Fentanyl abuse and dependence: further evidence for second hand exposure hypothesis. J Addict Dis 2006 25 15-21
54. American Medical Association. The sick physician. Impairment by psychiatric disorders, including alcoholism and drug dependence. Jama 1973 223 684-687
55. Beaujouan L, Czernichow S, Pourriat JL, Bonnet F. (Prevalence and risk factors for substance abuse and dependence among anaesthetists: a national survey). Ann Fr Anesth Reanim 2005 24 471-479
56. Collins GB, McAllister MS, Jensen M, Gooden TA. Chemical dependency treatment outcomes of residents in anesthesiology: results of a survey. Anesth Analg 2005 101 1457-1462
57. Hughes PH, N. Brandenburg N, Baldwin DC, Storr L. Prevalence of substance use among US physiciens. J Amer med Ass 1992 267 2333-2339
58. Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia's Impaired Physicians Program. Review of the first 1000 physicians: analysis of specialty. Jama 1987 257 2927-2930
59. Mäulen B, Gottschaldt M, Feuerlein W, Bonitz G. Abhängigkeit bei Ärzten Eine klinische Studie zu Betroffenen in der Bundesrepublik Deutschland. Münch Med Wschr 1991 133 446-449
60. Boyd JW, Knight JR. Substance use disorders among physicians. In: Galanter M Kleber HD (editors) Textbook of substance abuse treatment. Washington London American Psychiatric Publishing 4th edition 2008 609-621
61. Booth JY, Grossman D, Moore J, Lineberger C, Reynolds JD, Reves JG, Sheffield D. Substance abuse among physicians: A survey of academic anesthesiology programs. Anesth Analg 2002 95 1024-1030
62. Lemke J, Maier C, Schüttler J, Scherbaum N, Bürkle H, Kaisers U, Soukup J. Medikamentenmissbrauch in Anästhesiologie und Intensivmedizin. Der Schmerz 2009 23 76-76
63. Centrella M. Physician addiction and impairment current thinking: a review. J Addict Dis 1994 13 91-105
64. Shapiro CS, Fluharty DC. Relapse factors in chemically dépendent female physiciens. Arizona Int Conference Phys Hlth 1996 247-247
65. Zacny JP, Lichtor JL, Thompson W, Apfelbaum JL. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesth Analg 1993 77 544-552
66. Follette JW, Farley WJ. Anesthesiologist addicted to propofol. Anesthesiology 1992 77 817-818
67. Iwersen-Bergmann S, Rosner P, Kuhnau HC, Junge M, Schmoldt A. Death after excessive propofol abuse. Int J Legal Med 2001 114 248-251
68. Nutt D, King LA, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007 369 1047-1053
69. Roussin A, Mirepoix M, Lassabe G, Dumestre-Toulet V, Gardette V, Montastruc JL, Lapeyre-Mestre M. Death related to a recreational abuse of propofol at therapeutic dose range. Br J Anaesth 2006 97 268-268
70. Odell M. Propofolabuse. Anaesth Intensive Care 1999 27 539-539
71. Kintz P, Villain M, Dumestre V, Cirimele V. Evidence and addiction by anesthesiologists documented by hair analysis. Forensic Sci Int 2005 153 81-84
72. Bobo WV, Miller SC. Ketamine as a preferred substance of abuse. Am J Addict 2002 11 332-334
73. Siegel RK. Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr 1978 119-147
74. Schifano F, Corkery J, Oyefeso A, Tonia T, Ghodse AH. Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (19932006). J Clin Psychopharmacol 2008 28 114-116
75. Levine B, Cox D, Jufer-Phipps RA et al. A fatality from sevoflurane abuse. J Anal Toxicol 2007 31 534-536
76. Wilson JE, Kiselanova N, Stevens Q et al. A survey of inhalational anaesthetic abuse in anaesthesia training programmes. Anaesthesia 2008 63 616-620
77. Gallegos KV, Lubin BH, Bowers C et al. Relapse and recovery: five to ten year follow-up study of chemically dependent physicians the Georgia experience. Md Med J 1992 41 315-319
78. Mäulen B. Gute Therapieerfolge bei abhängigen Ärzten. Kassenarzt 1996 36 48-52
79. Broocke D, Edwards G, Taylor C. Addiction as an occupational hazard: 144 doctors with drug and alcohol problems. Br J Addict 1991 86 1011-1016
80. Wolff K, Winstock AR. Ketamine: from medicine to misuse. CNS Drugs 2006 20 199-218